Vertex Pharmaceutical Shares Move Lower; Stat News Reports ‘Vertex shelves second drug for inherited lung disease, raising concerns about future growth’
Shares of Baker Hughes (NYSE:BKR) moved higher by 4.8% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 300.00% over the past year to $0.10, which missed the estimate of $0.16.